The bank began research coverage of the women’s health drugmaker that was spun out of Merck with an overweight rating.
You are here: Home / Barclays says this women’s health pharma company could rally 48%
Market News and Views
The bank began research coverage of the women’s health drugmaker that was spun out of Merck with an overweight rating.